Readability User Testing is used to ensure that a set group of people are able to understand and act upon the information given in a Patient Information Leaflet (PIL). This test is conducted as a regulatory requirement within the pharmaceutical sector to improve the readability of PILs.
We offer our clients a free assessment of their portfolio of products and then advise them accordingly to ensure full compliance with Readability User Testing (RUT) requirements.
We aim to ensure that the demographic characteristics of the group tested correspond to those of the territory where the product is to be marketed, while taking into account all national as well as European Medicines Agency (EMA) requirements.
Bridging studies can minimise the number of RUT to be conducted if a new “daughter” PIL is similar to the original “parent” PIL.
We have vast experience in this field and here again we can help you save time and money by using this system and in some cases across different languages.
Focus-testing can be implemented in the case of a small number of significant differences in the contents of the PIL.
We have participated in over 1,500 RT and Bridging Studies, meeting our clients’ needs in any country where it was required. We conduct the tests in the local/national language as required. We started our commercial activity by offering our customers RT, so our experience, references and the number of successfully delivered projects endorse our services.
We have an experienced multilingual team of professionals who always adopt a project-oriented approach. Thanks to this multi-language management, we ensure that the results are understandable to everyone in any language.
If you are interested in our service please contact us for more information.
Telephone: +353 125 44033